Funding for this research was provided by:
Health Resources and Services Administration (U69HA30462)
National Institute on Drug Abuse (T32-DA041898-03)
Received: 10 March 2022
Accepted: 5 October 2022
First Online: 17 October 2022
: The Institutional Review Boards of the Boston University Charles River Campus and Boston University Medical Center approved all study protocols. All participants included in the study completed informed consent in accordance with the IRB protocol.
: Not Applicable.
: The authors have no conflicts of interest to disclose.